Middle-ear infection, or otitis media, usually caused by bacteria or viruses and it requires high doses of oral antibiotics to cure. This high dose of oral antibiotics may cause side effects like diarrhea; rashes and oral thrush are common. Symptoms include pain and fever and in some cases. It may also cause drainage of fluid from the ear or hearing loss. Although most infections go away on their own, some require antibiotics. US researchers has developed a single dose of a bioengineered gel could deliver a full course of antibiotic therapy for a common childhood ear infection much easier and potentially safer.

Researchers led by Boston Children Hospital in the US said, ear infection is the number one reason for pediatric antibiotic prescriptions, but getting oral antibiotics into young children several times a day for seven to 10 days is a difficult task.

Squirted into the ear canal, the gel quickly hardens and stays in place and gradually dispensing antibiotics across the eardrum into the middle ear. Daniel Kohane from Boston Children’s Hospital said “Our technology gets things across the eardrum that don’t usually get across in sufficient quantity to be therapeutic,”

Previously the tympanic membrane was an impenetrable barrier, but the bioengineered gel gets drugs past it with the help of chemical permeation enhancers (CPEs). The CPEs insert themselves into the membrane and opening up molecular pores that allow the antibiotics to seep through to the eardrum’s outermost layer.

Stephen Pelton, paediatrician at Boston Medical Center said, “Transtympanic delivery of antibiotics to the middle ear has the capacity to enable children to benefit from the rapid antibacterial activity of antimicrobial agents without systemic exposure and could reduce emergence of resistant microbes”. READ ALSO: Now, Your smartphone can help Diagnose Ear Infection.

The Indian Express

Other News

  • Medical Devices

India Medical Device Pricing Strategy: Ensuring Growth & Affordability

India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]

Read More

Imports of High-Value Medical Equipment

High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]

Read More

SEC Committee: Pioneering Medical Approvals

New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]

Read More
  • ErlySign's Oral Cancer Detection

ErlySign Oral Cancer Detection Technology Gets CDSCO Nod

ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]

Read More

Additional Steps Announced by FDA to Modernize Clinical Trials

The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]

Read More

Accreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA 

This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]

Read More

BSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing

BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]

Read More

TUV SUD Inspects IVD Medical Devices’ Cyber Security

The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]

Read More